FDA issues bismacine-chromacine warning

Jul 24, 2006

The U.S. Food and Drug Administration is warning consumers and healthcare providers not to use a product called bismacine, also known as chromacine.

The FDA says it is investigating one report of a death and several reports of injury related to the administration of bismacine -- an injectable product that has been used to treat Lyme disease.

FDA officials said bismacine, which is not approved for anything, including Lyme disease, is not a pharmaceutical and is mixed individually by druggists. It is prescribed or administered by doctors of "alternative health" or by people claiming to be medical doctors.

The product contains high amounts of bismuth, a heavy metal that is used in some medications to treat Helicobacter pylori, a bacteria that can cause stomach ulcers but that is not approved in any form for use by injection.

Copyright 2006 by United Press International

Explore further: Researchers discover low-grade nonwoven cotton picks up 50 times own weight of oil

add to favorites email to friend print save as pdf

Related Stories

Scalping can raise ticket prices

5 hours ago

Scalping gets a bad rap. For years, artists and concert promoters have stigmatized ticket resale as a practice that unfairly hurts their own sales and forces fans to pay exorbitant prices for tickets to sold-out concerts. ...

Tropical Storm Genevieve forms in Eastern Pacific

7 hours ago

The seventh tropical depression of the Eastern Pacific Ocean formed and quickly ramped up to a tropical storm named "Genevieve." NOAA's GOES-West satellite captured an infrared image of the newborn storm ...

Recommended for you

Research looks to combat US Latina immigrant obesity

4 hours ago

According to the U.S. Census Bureau, Latinos are the largest minority group in the United States, comprising 16.7% of the population. Approximately one-third of Latinos are obese and are 1.2 times as likely to be obese compared ...

User comments : 0